Oaktree Acquisition Corp. II
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch OACB and buy or sell other stocks, ETFs, and their options commission-free!About OACB
Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates.
CEOVilhelm Róbert Wessman
CEOVilhelm Róbert Wessman
Employees1,032
Employees1,032
HeadquartersLuxembourg, Luxembourg
HeadquartersLuxembourg, Luxembourg
Founded2021
Founded2021
Employees1,032
Employees1,032
OACB Key Statistics
Market cap2.83B
Market cap2.83B
Price-Earnings ratio24.19
Price-Earnings ratio24.19
Dividend yield—
Dividend yield—
Average volume638.62K
Average volume638.62K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$13.70
52 Week high$13.70
52 Week low$4.32
52 Week low$4.32
Stock Snapshot
Oaktree Acquisition Corp. II(OACB) stock is priced at $9.38, giving the company a market capitalization of 2.83B. It carries a P/E multiple of 24.19.
On 2025-12-14, Oaktree Acquisition Corp. II(OACB) stock opened at —, reached a high of —, and a low of —.
The Oaktree Acquisition Corp. II(OACB)'s current trading volume is 0, compared to an average daily volume of 638.62K.
During the past year, Oaktree Acquisition Corp. II(OACB) stock moved between $4.32 at its lowest and $13.70 at its peak.
During the past year, Oaktree Acquisition Corp. II(OACB) stock moved between $4.32 at its lowest and $13.70 at its peak.
People also own
Based on the portfolios of people who own OACB. This list is generated using Robinhood data, and it’s not a recommendation.